The Bioavailability of Mycoprotein

Not Applicable

Completed

• Conditions: Availability of Mycoprotein
• Interventions: Other: Mycoprotein ingestion

• Registration Number: NCT04233411
• Lead Sponsor: University of Exeter

Brief Summary

To evaluate the bioavailability of mycoprotein, compared with a reference animal based protein, in a dose-response manner.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-01
• Study First Submitted: 2016-11-30
• Primary Completion: 2017-08
• Study Completion: 2018-01
• Status Verified: 2020-01
• Study First Submitted QC: 2020-01-15
• Last Update Submitted: 2020-01-15
• Study First Posted: 2020-01-18
• Last Update Posted: 2020-01-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 12

Inclusion Criteria

• Healthy and aged 18-40 y
• BMI between 18 and 30

Read More

Exclusion Criteria

• On medication
• Family history of metabolic disease
• Diagnosed with any metabolic or cardiovascular conditions
• BMI < 18 or > 30

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
60g	Mycoprotein ingestion	Acute ingestion of 60 g mycoprotein
80g	Mycoprotein ingestion	Acute ingestion of 60 g mycoprotein
Milk	Mycoprotein ingestion	Acute ingestion of 20 g milk protein
20g	Mycoprotein ingestion	Acute ingestion of 20 g mycoprotein
40g	Mycoprotein ingestion	Acute ingestion of 40 g mycoprotein

Primary Outcome Measures

Name	Time	Method
Plasma total amino acid concentrations	4 hours

Trial Locations

Locations (1)

Sport & Health Sciences; 🇬🇧 Exeter, Devon, United Kingdom